Article
Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults.
Environmental health perspectives - 1 Sept 2005
Rajaraman Preetha, Schwartz Brian S, Rothman Nathaniel, Yeager Meredith, Fine Howard A, Shapiro William R, Selker Robert G, Black Peter M, Inskip Peter D
Abstract excerpt
The enzyme delta-aminolevulinic acid dehydratase (ALAD), which catalyzes the second step of heme synthesis, can be inhibited by several chemicals, including lead, a potential risk factor for brain tumors, particularly meningioma. In this study we examined whether the ALAD G177C polymorphism in the gene coding for ALAD is associated with risk of intracranial tumors of the brain and nervous system. We use data from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
